Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis
This study has been terminated.
(Difficulty recruiting)
Sponsor:
Innovaderm Research Inc.
Collaborator:
Janssen-Ortho LLC
Information provided by (Responsible Party):
Innovaderm Research Inc.
ClinicalTrials.gov Identifier:
NCT01091051
First received: March 18, 2010
Last updated: August 6, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | November 2011 |
| Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |